Mourabit Halima, Author at MediaMedic

Dr. Liang Han: Phase III MATTERHORN Study Shows Significant Improvement in pCR for Neoadjuvant Treatment of Gastric Cancer with Pembrolizumab

By Mourabit Halima 2023.12.05

Editor's Note:This 2023 ESMO Annual Meeting, in the field of gastric cancer, the global Phase III MATTERHORN study of the anti-PD-L1 antibody pembrolizumab in combination with the FLOT regimen for…

ESMO Exclusive Interview | Professor Huiyan Luo : Significant Efficacy of the Combination of Anti-PD-L1/TGF-βRII Dual-Target Antibody SHR-1701 with Bevacizumab in the Treatment of Advanced Solid Tumors

By Mourabit Halima 2023.12.04

Editor's Note: The 2023 European Society for Medical Oncology (ESMO) Annual Meeting took place from October 20th to 24th in Madrid, Spain. The Oncology Insights Reporting Team delved deep into…

ESMO Big Shot Face to Face | Professor Shun Lu : Roxadustat Leads the Way in CIA Management

By Mourabit Halima 2023.12.04

The 2023 European Society for Medical Oncology (ESMO) Congress opened grandly in Madrid, Spain on October 20. Top global oncology experts gathered to discuss and share the latest international advances…